Genetic counselling and testing in Europe

Area of Science:

• Medical Genetics
• Health Services Research
• Genomic Medicine

Background:

• Current healthcare systems face challenges in managing genetic disorders due to rapid advances in genetics.
• There is a need to evaluate the capacity of non-specialist physicians and primary care providers in addressing genetic issues.
• Assessing the adequacy of resources within specialist genetic centers is crucial for meeting patient referral demands.

Purpose of the Study:

• To investigate the ability of general practitioners to manage genetic problems encountered in clinical practice.
• To determine if specialist genetic centers possess sufficient resources for current and future patient referrals.
• To evaluate the recognition of genetic problems and appropriateness of referrals by primary care providers.

Main Methods:

• The study is based on three key research initiatives: the National Confidential Enquiry into Counselling for Genetic Disorders, the Concerted Action on Genetics Services in Europe, and the Primary Care for Genetics Patients study.
• The first two studies offer insights into genetic counseling in the UK and healthcare access/quality for genetic disorder patients across Europe.
• The ongoing third study examines referral and care patterns within diverse European healthcare systems.

Main Results:

• The National Confidential Enquiry into Counselling for Genetic Disorders and Concerted Action on Genetics Services in Europe provide unique perspectives on genetic counseling and service provision.
• These studies yield recommendations for improving genetic healthcare services based on their findings.
• The Primary Care for Genetics Patients study is actively collecting data on referral and care patterns.

Conclusions:

• Specialist genetic centers are identified as essential resources for future integrated genetic services, despite a projected shortage of medical geneticists.
• Clinical geneticists are expected to play an expanded role, complementing the diagnosis of rare genetic syndromes.
• Healthcare systems require significant preparation to effectively integrate the implications of ongoing genetic advancements.